News | March 28, 2022
Aurobindo enters domestic formulations space with the acquisition of Veritaz for Rs 171 Cr
Veritaz has over 40 brands marketed across the acute and critical care therapeutic segments
Veritaz has over 40 brands marketed across the acute and critical care therapeutic segments
Casimir further differentiates Emmes’ industry-leading rare disease research capabilities
Brazil has the 4th largest pet market in the world with an estimated market size of BRL 1.8 billion, growing annually at 16%
Mankind Pharma has agreed to retain Panacea Biotec’s sales and marketing team engaged in this business
Adds to Merck’s growing global, multi-modality CDMO network, following newly formed CDMO business unit in Life Science
CliniSys has the proven ability to deliver 100s of millions of medical results a month to enable pandemic-scale population disease surveillance across the globe
The combination enhances Comar's customer value proposition by adding complementary closure and jar products and related precision mold-making expertise
TIB Molbiol excels in ultra-rapid assay development for emerging infectious diseases, strongly demonstrated during the Covid-19 pandemic
The revised deal involves a cash consideration only as against the earlier proposal of cash and equity
_256_384.jpeg)
The company aims to continue its expansion via organic and inorganic routes to increase production capacity and product portfolio
Subscribe To Our Newsletter & Stay Updated
